Qlucore, a developer of bioinformatics software, has announced a licence contract with Cambridge Protein Arrays
Qlucore, a provider of bioinformatics visualization and analysis software, has launched the latest version of Qlucore Omics Explorer 3.4.
Qlucore and Nebion have started a collaboration to provide scientists with an end-to-end solution for gene expression analysis, by combining Qlucore Omics Explorer and Genevestigator into a single end to end software package
Rodin Therapeutics, a venture-backed biotechnology company that develops therapeutics for neurological disorders has announced that it uses Qlucore Omics Explorer to characterise its compounds response to treatment.
Qlucore, a provider of bioinformatics visualisation software, has announced the beta version of Qlucore Omics Explorer 3.3. This includes a completely new Next Generation Sequencing (NGS) Module, and range of new functionalities for the base version.
The NGS Module will enable additional functionality related to data generated with NGS technologies which will make it possible to dynamically visualise and analyse NGS data.
As part of its continued expansion into the US market Qlucore has announced the appointment of a new sales manager for the mid-Atlantic region, Beth Repetti.
Qlucore, a developer of bioinformatics software, has announced the launch of the Mac version of Qlucore Omics Explorer 3.1 data analysis software
Qlucore, a leader in the development of bioinformatics software, has announced a partnership with TATAA Biocenter, the world´s premier organizer of hands-on training in molecular diagnostics and Europe´s leading provider of genomic services
As the worlds 12th largest economy, South Korea is one of the fastest growing and most exciting markets in the world
In recent years, transcriptomic profiling via next generation sequencing (RNA-seq) has emerged as both a technical and cost-effective alternative to arrays
In January 2020 the American Diabetes Association released a new set of clinical standards that, for the first time, included the use of an FDA-approved autonomous artificial intelligence (AI) platform for detecting diabetic retinopathy in people with diabetes.
At the end of February physIQ and the US Department of Veteran’s Affairs published data from a clinical trial demonstrating the use of physIQ’s machine-learning algorithm to predict when an individual patient with previously diagnosed heart failure will likely require a readmission to hospital.
Cloud research tools provide a platform for new avenues of scientific research by providing fast access to bare-metal resources.
New processors and GPU technology continue to demand more power than the previous generations, combining this with increasingly dense architectures requires cooling solutions such as liquid or immersion cooling.
Tate Cantrell, CTO, Verne Global, comments on the cost of the AI computing revolution
European researchers are working on a new programming environment for exascale computing that aims to make using these systems more efficient and programmers more productive.
